Research gap
A research opportunity connected to missing evidence, methods, datasets, validation, or translation.
Gap type
Priority
Evidence
Status
Followers
Evidence links
Preparing research brief
The platform is organizing evidence for this page. Linked papers and discussion remain available while the brief is prepared.
The first accepted evidence set for GLP-1 receptor agonists for obesity treatment includes 12 papers. Evidence currently spans 2019 to 2025. Methods represented in the accepted evidence include 72-week, double-blind, phase 2 trial, Examination of cardiovascular outcome studies, Open-label, 40-week, phase 3 randomized trial. The most specific unresolved gap is unresolved evidence gap around ror does not prove causation. Paper intelligence specifically flags: ROR does not prove causation; Short study duration of 40 weeks; Open-label design may introduce bias. This gap should be tracked as topic memory, paper intelligence, and future accepted evidence mature.
Current barriers will appear when evidence is linked or reviewed.
The Effect of Semaglutide and GLP-1 RAs on Risk of Nonarteritic Anterior Ischemic Optic Neuropathy
Nadia J Abbass; Raya Nahlawi; Jacqueline K. Shaia; Kevin Allan; David C. Kaelber; Katherine E. Talcott; Rishi P. Singh · 2025 · American Journal of Ophthalmology
GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach
Jingyue Wang; Quanwei Wang; Xinyu Yang; Wei Yang; Dong-Rui Li; Jingyu Jin; Hui-Cong Zhang; Xianfeng Zhang · 2023 · Frontiers in Endocrinology
Future work suggestions will appear when the gap has enough evidence.
Possible methods or datasets
Suggest cohorts, benchmarks, validation settings, or datasets that would make this gap testable.
Translational opportunity
Connect the gap to engineering, clinical, or deployment contexts where a stronger answer would matter.
Timeline entries will appear as linked evidence accumulates.
Public discussions linked to this gap will appear here.
Suggest evidence
Add papers or datasets that demonstrate, narrow, or challenge this gap.
Suggest an update
Help refine the gap when new studies change the opportunity.
Follow updates
Save or follow this gap to track how the evidence evolves.
Signal current status
Useful contributions cite evidence, clarify uncertainty, or explain why the object has changed.
GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
Xin Zhao; Minghe Wang; Zhitong Wen; Zhihong Lu; Lijuan Cui; Chao Fu; Huan Xue; Yunfeng Liu; Yi Zhang · 2021 · Frontiers in Endocrinology
Existing attempts will appear when papers are linked.
Limitations will be summarized from reviewed evidence when available.